143 related articles for article (PubMed ID: 9657738)
21. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.
Tepler I; Elias L; Smith JW; Hussein M; Rosen G; Chang AY; Moore JO; Gordon MS; Kuca B; Beach KJ; Loewy JW; Garnick MB; Kaye JA
Blood; 1996 May; 87(9):3607-14. PubMed ID: 8611684
[TBL] [Abstract][Full Text] [Related]
22. Cost of chemotherapy-induced thrombocytopenia among patients with lymphoma or solid tumors.
Elting LS; Cantor SB; Martin CG; Hamblin L; Kurtin D; Rivera E; Vadhan-Raj S; Benjamin RS
Cancer; 2003 Mar; 97(6):1541-50. PubMed ID: 12627519
[TBL] [Abstract][Full Text] [Related]
23. Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy.
Comont T; Tavitian S; Bardiaux L; Fort M; Debiol B; Morère D; Bérard E; Delabesse E; Luquet I; Martinez S; Huguet F; Récher C; Bertoli S
Leuk Res; 2017 Oct; 61():62-67. PubMed ID: 28910610
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of platelet transfusions in immune thrombocytopenia.
Carr JM; Kruskall MS; Kaye JA; Robinson SH
Am J Med; 1986 Jun; 80(6):1051-4. PubMed ID: 3728504
[TBL] [Abstract][Full Text] [Related]
25. Conservative management of chemotherapeutic-induced thrombocytopenia in women with gynecologic cancers.
Fanning J; Hilgers RD; Murray KP; Bolt K; Aughenbaugh DM
Gynecol Oncol; 1995 Nov; 59(2):191-3. PubMed ID: 7590471
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy of rhIL-11.
Reynolds CH
Oncology (Williston Park); 2000 Sep; 14(9 Suppl 8):32-40. PubMed ID: 11033836
[TBL] [Abstract][Full Text] [Related]
27. Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: an unresolved problem and possible approaches to resolve it.
Hassan HT; Zander AR
J Hematother; 1996 Aug; 5(4):407-14. PubMed ID: 8877716
[TBL] [Abstract][Full Text] [Related]
28. Platelet Transfusions in Patients with Hypoproliferative Thrombocytopenia: Conclusions from Clinical Trials and Current Controversies.
Crighton GL; Estcourt LJ; Wood EM; Stanworth SJ
Hematol Oncol Clin North Am; 2016 Jun; 30(3):541-60. PubMed ID: 27112995
[TBL] [Abstract][Full Text] [Related]
29. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
30. Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses.
Anglin CO; Spence JS; Warner MA; Paliotta C; Harper C; Moore C; Sarode R; Madden C; Diaz-Arrastia R
J Neurosurg; 2013 Mar; 118(3):676-86. PubMed ID: 23259827
[TBL] [Abstract][Full Text] [Related]
31. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
Vadhan-Raj S; Verschraegen CF; Bueso-Ramos C; Broxmeyer HE; Kudelkà AP; Freedman RS; Edwards CL; Gershenson D; Jones D; Ashby M; Kavanagh JJ
Ann Intern Med; 2000 Mar; 132(5):364-8. PubMed ID: 10691586
[TBL] [Abstract][Full Text] [Related]
33. Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial.
Klumpp TR; Herman JH; Gaughan JP; Russo RR; Christman RA; Goldberg SL; Ackerman SJ; Bleecker GC; Mangan KF
Transfusion; 1999 Jul; 39(7):674-81. PubMed ID: 10413273
[TBL] [Abstract][Full Text] [Related]
34. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
[TBL] [Abstract][Full Text] [Related]
35. Prospective, randomized trial of 5-fluorouracil, leucovorin, doxorubicin, and cyclophosphamide chemotherapy in combination with the interleukin-3/granulocyte-macrophage colony-stimulating factor (GM-CSF) fusion protein (PIXY321) versus GM-CSF in patients with advanced breast cancer.
O'Shaughnessy JA; Tolcher A; Riseberg D; Venzon D; Zujewski J; Noone M; Gossard M; Danforth D; Jacobson J; Chang V; Goldspiel B; Keegan P; Giusti R; Cowan KH
Blood; 1996 Mar; 87(6):2205-11. PubMed ID: 8630380
[TBL] [Abstract][Full Text] [Related]
36. Predicting chemotherapy-induced thrombocytopenia in cancer patients with solid tumors or lymphoma.
Razzaghdoust A; Mofid B; Zangeneh M
J Oncol Pharm Pract; 2020 Apr; 26(3):587-594. PubMed ID: 31315547
[TBL] [Abstract][Full Text] [Related]
37. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.
Vinholt PJ; Alnor A; Nybo M; Hvas AM
Platelets; 2016 Sep; 27(6):547-54. PubMed ID: 27025360
[TBL] [Abstract][Full Text] [Related]
38. Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy.
Cantor SB; Elting LS; Hudson DV; Rubenstein EB
Cancer; 2003 Jun; 97(12):3099-106. PubMed ID: 12784347
[TBL] [Abstract][Full Text] [Related]
39. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
[TBL] [Abstract][Full Text] [Related]
40. [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia].
Wang XY; Feng FY; Song ST; Wang HQ; Zhang MH; Liu J; Liu XY; Xu LG; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):373-6. PubMed ID: 16117903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
